Logo image of STVN

STEVANATO GROUP SPA (STVN) Stock Overview

NYSE:STVN - IT0005452658 - Common Stock

22.23 USD
-0.62 (-2.71%)
Last: 8/22/2025, 12:48:02 PM

STVN Key Statistics, Chart & Performance

Key Statistics
52 Week High28
52 Week Low17.12
Market Cap6.07B
Shares272.90M
Float48.78M
Yearly Dividend0.06
Dividend Yield0.28%
EPS(TTM)0.61
PE36.44
Fwd PE28.91
Earnings (Next)10-27 2025-10-27/amc
IPO07-16 2021-07-16
Sector
GICS SectorHealth Care
GICS IndustryLife Sciences Tools & Services
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryLife Sciences Tools & Services


STVN short term performance overview.The bars show the price performance of STVN in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 5 -5 -10 -15

STVN long term performance overview.The bars show the price performance of STVN in the last 1, 2 and 3 years. 1 year 2 years 3 years 0 20 -20

The current stock price of STVN is 22.23 USD. In the past month the price decreased by -18.25%. In the past year, price increased by 22.85%.

STEVANATO GROUP SPA / STVN Daily stock chart

STVN Competitors/Peers

The largest stocks on the US markets in the "Life Sciences Tools & Services" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
TMO THERMO FISHER SCIENTIFIC INC 22.85 188.85B
DHR DANAHER CORP 28.05 151.22B
A AGILENT TECHNOLOGIES INC 22.58 34.64B
IQV IQVIA HOLDINGS INC 16.76 32.68B
MTD METTLER-TOLEDO INTERNATIONAL 32.58 27.69B
WAT WATERS CORP 24.86 18.09B
WST WEST PHARMACEUTICAL SERVICES 35.4 17.72B
ILMN ILLUMINA INC 24.61 16.21B
TEM TEMPUS AI INC N/A 14.28B
ICLR ICON PLC 13.45 13.84B
MEDP MEDPACE HOLDINGS INC 34.51 13.04B
RVTY REVVITY INC 19.3 11.13B

About STVN

Company Profile

STVN logo image Stevanato Group SpA engages in the provision of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. The company is headquartered in Piombino Dese, Padova and currently employs 5,521 full-time employees. The company went IPO on 2021-07-16. The firm delivers products, processes, and services across all stages of drug developments, including pre-clinical, clinical, and commercialization. Its Engineering segment includes the equipment and technologies developed and provided to support the end-to-end pharmaceutical, biotechnology, and diagnostic manufacturing processes. The firm operates locally, in Europe, and globally, including Brazil, China, Mexico, and the United States.

Company Info

STEVANATO GROUP SPA

Piombino Dese (Pd) Via Molinella, 17

Piombino Dese PADOVA IT

CEO: Franco Moro

Employees: 5635

STVN Company Website

STVN Investor Relations

Phone: 390499318173

STEVANATO GROUP SPA / STVN FAQ

What is the stock price of STEVANATO GROUP SPA today?

The current stock price of STVN is 22.23 USD. The price decreased by -2.71% in the last trading session.


What is the ticker symbol for STEVANATO GROUP SPA stock?

The exchange symbol of STEVANATO GROUP SPA is STVN and it is listed on the New York Stock Exchange, Inc. exchange.


On which exchange is STVN stock listed?

STVN stock is listed on the New York Stock Exchange, Inc. exchange.


What is the price forecast or stock price prediction for STEVANATO GROUP SPA stock?

17 analysts have analysed STVN and the average price target is 28.86 USD. This implies a price increase of 29.82% is expected in the next year compared to the current price of 22.23. Check the STEVANATO GROUP SPA stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is STEVANATO GROUP SPA worth?

STEVANATO GROUP SPA (STVN) has a market capitalization of 6.07B USD. This makes STVN a Mid Cap stock.


How many employees does STEVANATO GROUP SPA have?

STEVANATO GROUP SPA (STVN) currently has 5635 employees.


What are the support and resistance levels for STEVANATO GROUP SPA (STVN) stock?

STEVANATO GROUP SPA (STVN) has a support level at 22.62 and a resistance level at 22.86. Check the full technical report for a detailed analysis of STVN support and resistance levels.


Is STEVANATO GROUP SPA (STVN) expected to grow?

The Revenue of STEVANATO GROUP SPA (STVN) is expected to grow by 7.25% in the next year. Check the estimates tab for more information on the STVN EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy STEVANATO GROUP SPA (STVN) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does STEVANATO GROUP SPA (STVN) stock pay dividends?

STEVANATO GROUP SPA (STVN) has a dividend yield of 0.28%. The yearly dividend amount is currently 0.06. Check the full fundamental report for a detailed analysis of STVN dividend history, reliability and sustainability.


When does STEVANATO GROUP SPA (STVN) report earnings?

STEVANATO GROUP SPA (STVN) will report earnings on 2025-10-27, after the market close.


What is the Price/Earnings (PE) ratio of STEVANATO GROUP SPA (STVN)?

The PE ratio for STEVANATO GROUP SPA (STVN) is 36.44. This is based on the reported non-GAAP earnings per share of 0.61 and the current share price of 22.23 USD. Check the full fundamental report for a full analysis of the valuation metrics for STVN.


What is the Short Interest ratio of STEVANATO GROUP SPA (STVN) stock?

The outstanding short interest for STEVANATO GROUP SPA (STVN) is 4.15% of its float. Check the ownership tab for more information on the STVN short interest.


STVN Technical Analysis

ChartMill assigns a technical rating of 3 / 10 to STVN. When comparing the yearly performance of all stocks, STVN is one of the better performing stocks in the market, outperforming 74.77% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

STVN Fundamental Analysis

ChartMill assigns a fundamental rating of 5 / 10 to STVN. STVN has an excellent profitability rating, but there are some minor concerns on its financial health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

STVN Financial Highlights

Over the last trailing twelve months STVN reported a non-GAAP Earnings per Share(EPS) of 0.61. The EPS increased by 4% compared to the year before.


Industry RankSector Rank
PM (TTM) 11.75%
ROA 5.72%
ROE 9.63%
Debt/Equity 0.24
Chartmill High Growth Momentum
EPS Q2Q%22.22%
Sales Q2Q%7.86%
EPS 1Y (TTM)4%
Revenue 1Y (TTM)5.28%

STVN Forecast & Estimates

17 analysts have analysed STVN and the average price target is 28.86 USD. This implies a price increase of 29.82% is expected in the next year compared to the current price of 22.23.

For the next year, analysts expect an EPS growth of 12.43% and a revenue growth 7.25% for STVN


Analysts
Analysts83.53
Price Target28.86 (29.82%)
EPS Next Y12.43%
Revenue Next Year7.25%

STVN Ownership

Ownership
Inst Owners112.76%
Ins Owners1.61%
Short Float %4.15%
Short Ratio5.79